相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment
Julia Carolin Stingl et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Generation of induced pluripotent stem cells from human blood
Yuin-Han Loh et al.
BLOOD (2009)
Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
Werner Schroth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population
Wichittra Tassaneeyakul et al.
PHARMACOGENETICS AND GENOMICS (2009)
Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group
C. M. Bromley et al.
PHARMACOGENOMICS JOURNAL (2009)
The Potential of a Placebo/Nocebo Effect in Pharmacogenetics
S. B. Haga et al.
PUBLIC HEALTH GENOMICS (2009)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
Christine Lonjou et al.
PHARMACOGENETICS AND GENOMICS (2008)
Pharmacogenomics with antidepressants in the STAR*D study
E-Gene Lin et al.
PHARMACOGENOMICS (2008)
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
P. Brent Ferrell et al.
PHARMACOGENOMICS (2008)
Methodological quality of pharmacogenetic studies: Issues of concern
Andrea L. Jorgensen et al.
STATISTICS IN MEDICINE (2008)
Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines
Edwin Choy et al.
PLOS GENETICS (2008)
Assessment of cumulative evidence on genetic associations: interim guidelines
John P.A. Ioannidis et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
Jeffrey L. Anderson et al.
CIRCULATION (2007)
Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study
Hans Mulder et al.
ANNALS OF PHARMACOTHERAPY (2007)
Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans
Kari T. Kivisto et al.
PHARMACEUTICAL RESEARCH (2007)
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine
M. E. E. Shams et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Pharmacogenetics-based therapeutic recommendations -: ready for clinical practice?
J Kirchheiner et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Challenges in using nonrandomized studies in systematic reviews of treatment interventions
SL Norris et al.
ANNALS OF INTERNAL MEDICINE (2005)
Challenges in systematic reviews of diagnostic technologies
A Tatsioni et al.
ANNALS OF INTERNAL MEDICINE (2005)
Statistical design and analysis of pharmacogenetic trials
PJ Kelly et al.
STATISTICS IN MEDICINE (2005)
Clinical consequences of cytochrome P4502C9 polymorphisms
J Kirchheiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Pharmacogenetics of antidepressants and antipsychotics:: the contribution of allelic variations to the phenotype of drug response
J Kirchheiner et al.
MOLECULAR PSYCHIATRY (2004)
Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials
GCS Smith et al.
BRITISH MEDICAL JOURNAL (2003)
CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants:: a first step towards subpopulation-specific dosages
J Kirchheiner et al.
ACTA PSYCHIATRICA SCANDINAVICA (2001)
Ethical considerations in clinical pharmacogenomics research
AM Issa
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
Venlafaxine serum levels and CYP2D6 genotype
AH Veefkind et al.
THERAPEUTIC DRUG MONITORING (2000)
分享论文
